- This study will enroll pediatric and adult subjects with glaucoma or ocular
hypertension receiving treatment with latanoprost in either one or both eyes for at
least two weeks.
- The pediatric subjects will be grouped by age (0 to years).
- Ocular inflammation/infection or a history of ocular inflammation/infection within 3
months prior to the screening visit.
- History of ocular trauma or surgery in either eye within 14-days of the screening
- Use of continuous wear contact lenses.